Treating COVID-19 with colchicine in community healthcare setting

doi:10.1016/j.clim.2020.108490

. 2020 Aug:217:108490.

doi: 10.1016/j.clim.2020.108490. Epub 2020 May 31.

Treating COVID-19 with colchicine in community healthcare setting

Emanuel Della-Torre¹, Fabrizio Della-Torre², Marija Kusanovic³, Raffaella Scotti⁴, Giuseppe Alvise Ramirez⁵, Lorenzo Dagna⁵, Moreno Tresoldi⁴

Affiliations

¹ Università Vita-Salute San Raffaele, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: dellatorre.emanuel@hsr.it.
² Centro Medico Sant'Agostino, Milan, Italy.
³ ATS Milano Città Metropolitana, Milan, Italy.
⁴ Unit of General Medicine and Advanced Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁵ Università Vita-Salute San Raffaele, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

PMID: 32492478
PMCID: PMC7261351
DOI: 10.1016/j.clim.2020.108490

Treating COVID-19 with colchicine in community healthcare setting

Emanuel Della-Torre et al. Clin Immunol. 2020 Aug.

. 2020 Aug:217:108490.

doi: 10.1016/j.clim.2020.108490. Epub 2020 May 31.

Authors

Emanuel Della-Torre¹, Fabrizio Della-Torre², Marija Kusanovic³, Raffaella Scotti⁴, Giuseppe Alvise Ramirez⁵, Lorenzo Dagna⁵, Moreno Tresoldi⁴

Affiliations

¹ Università Vita-Salute San Raffaele, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: dellatorre.emanuel@hsr.it.
² Centro Medico Sant'Agostino, Milan, Italy.
³ ATS Milano Città Metropolitana, Milan, Italy.
⁴ Unit of General Medicine and Advanced Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁵ Università Vita-Salute San Raffaele, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

PMID: 32492478
PMCID: PMC7261351
DOI: 10.1016/j.clim.2020.108490

No abstract available

Keywords: COVID-19; Colchicine; Community; Inflammation; SARS-CoV-2.

PubMed Disclaimer

Figures

**Fig. 1**
Time-course of fever progression in patients treated with colchicine.

See this image and copyright information in PMC

Cited by

Does SARS-CoV-2 Induce IgG4 Synthesis to Evade the Immune System?
Rubio-Casillas A, Redwan EM, Uversky VN. Rubio-Casillas A, et al. Biomolecules. 2023 Sep 1;13(9):1338. doi: 10.3390/biom13091338. Biomolecules. 2023. PMID: 37759738 Free PMC article.
Neutrophils in COVID-19: recent insights and advances.
Li J, Zhang K, Zhang Y, Gu Z, Huang C. Li J, et al. Virol J. 2023 Aug 2;20(1):169. doi: 10.1186/s12985-023-02116-w. Virol J. 2023. PMID: 37533131 Free PMC article. Review.
COVID-19 and candiduria: an investigation of the risk factors and immunological aspects.
Singulani JL, Silva DL, Lima CM, Magalhães VCR, Baltazar LM, Moura AS, Santos ARO, Fereguetti T, Martins JC, Rabelo LF, Lyon AC, Martins-Filho OA, Johann S, Peres NTA, Coelho Dos Reis JGA, Santos DA. Singulani JL, et al. Braz J Microbiol. 2023 Sep;54(3):1783-1793. doi: 10.1007/s42770-023-01042-x. Epub 2023 Jul 5. Braz J Microbiol. 2023. PMID: 37405625 Free PMC article.
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology.
Wang M, Yu F, Chang W, Zhang Y, Zhang L, Li P. Wang M, et al. Front Immunol. 2023 May 12;14:1185233. doi: 10.3389/fimmu.2023.1185233. eCollection 2023. Front Immunol. 2023. PMID: 37251383 Free PMC article. Review.
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein.
Uversky VN, Redwan EM, Makis W, Rubio-Casillas A. Uversky VN, et al. Vaccines (Basel). 2023 May 17;11(5):991. doi: 10.3390/vaccines11050991. Vaccines (Basel). 2023. PMID: 37243095 Free PMC article. Review.

See all "Cited by" articles

References

1. Wang Dawei, Hu Bo, Hu Chang. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020:e201585. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed
1. Yuki K., Fujiogi M., Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin. Immunol. 2020;215 doi: 10.1016/j.clim.2020.108427. - DOI - PMC - PubMed
1. Felsenstein S., Herbert J.A., McNamara P.S., Hedrich C.M. COVID-19: immunology and treatment options. Clin. Immunol. 2020;215 doi: 10.1016/j.clim.2020.108448. - DOI - PMC - PubMed
1. Remuzzi G., Remuzzi A. COVID-19 and Italy: what next? Lancet. 2020;395:1225–1228. - PMC - PubMed
1. Mancuso G., Boffini N., Dagna L. Colchicine as a new therapeutic option for antithyroid arthritis syndrome. Rheumatology (Oxford) 2019:kez547. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Wang Dawei, Hu Bo, Hu Chang. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020:e201585. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed

[2] Wang Dawei, Hu Bo, Hu Chang. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020:e201585. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed

[3] Yuki K., Fujiogi M., Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin. Immunol. 2020;215 doi: 10.1016/j.clim.2020.108427. - DOI - PMC - PubMed

[4] Yuki K., Fujiogi M., Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin. Immunol. 2020;215 doi: 10.1016/j.clim.2020.108427. - DOI - PMC - PubMed

[5] Felsenstein S., Herbert J.A., McNamara P.S., Hedrich C.M. COVID-19: immunology and treatment options. Clin. Immunol. 2020;215 doi: 10.1016/j.clim.2020.108448. - DOI - PMC - PubMed

[6] Felsenstein S., Herbert J.A., McNamara P.S., Hedrich C.M. COVID-19: immunology and treatment options. Clin. Immunol. 2020;215 doi: 10.1016/j.clim.2020.108448. - DOI - PMC - PubMed

[7] Remuzzi G., Remuzzi A. COVID-19 and Italy: what next? Lancet. 2020;395:1225–1228. - PMC - PubMed

[8] Remuzzi G., Remuzzi A. COVID-19 and Italy: what next? Lancet. 2020;395:1225–1228. - PMC - PubMed

[9] Mancuso G., Boffini N., Dagna L. Colchicine as a new therapeutic option for antithyroid arthritis syndrome. Rheumatology (Oxford) 2019:kez547. - PubMed

[10] Mancuso G., Boffini N., Dagna L. Colchicine as a new therapeutic option for antithyroid arthritis syndrome. Rheumatology (Oxford) 2019:kez547. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Treating COVID-19 with colchicine in community healthcare setting

Affiliations

Treating COVID-19 with colchicine in community healthcare setting

Authors

Affiliations

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous